Bruderman Asset Management’s Purple Biotech PPBT Stock Holding History

Bruderman Asset Management’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	-$2K	–	443
2019 Q1	$2K	Hold	1	–	–	﹤0.01%	573
2018 Q4	$1K	Buy	+1	New	+$2.52K	﹤0.01%	624

Other funds holding PPBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bruderman Asset Management's PPBT Position: Q2 2019 in Review

Bruderman Asset Management sold out of Purple Biotech (PPBT) in Q2 2019, closing a stake of 1 share — an estimated $2K sold.

Bruderman Asset Management first reported a position in PPBT in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 5 funds tracked by Wall St. Rank hold PPBT as of Q2 2019.

Bruderman Asset Management reported no remaining Purple Biotech position as of Q2 2019 after selling out during the quarter.
Bruderman Asset Management sold 1 Purple Biotech share in Q2 2019, an estimated $2K.
Bruderman Asset Management first reported a position in Purple Biotech in Q4 2018 and held it in 2 quarters.
Bruderman Asset Management's Purple Biotech position peaked at $2K in Q1 2019.
5 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.